Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.

Saved in:
Bibliographic Details
Title: Differences in overall survival for invasive epithelial ovarian cancer by race and ethnicity: results from the Ovarian Cancer Association Consortium.
Authors: Meagher NS; The Daffodil Centre, The University of Sydney and Cancer Council NSW, Sydney, NSW, Australia.; Medicines Intelligence Program, School of Population Health, UNSW Medicine and Health, University of NSW, Sydney, NSW, Australia., White KK; Population Sciences in the Pacifi c Program (Cancer Epidemiology), University of Hawaii Cancer Center, Honolulu, HI, USA., Wilkens LR; Population Sciences in the Pacifi c Program (Cancer Epidemiology), University of Hawaii Cancer Center, Honolulu, HI, USA., Anton-Culver H; Department of Medicine, Genetic Epidemiology Research Institute, University of California Irvine, Irvine, CA, USA., Bandera EV; Cancer Prevention and Control Program, Rutgers Cancer Institute, New Brunswick, NJ, USA., Carney ME; Department of Obstetrics and Gynecology, John A. Burns School of Medicine, University of Hawaii, Honolulu, HI, USA., Cramer DW; Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA., Cushing-Haugen KL; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA., DeFazio A; The Daffodil Centre, The University of Sydney and Cancer Council NSW, Sydney, NSW, Australia.; Centre for Cancer Research, The Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.; Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, Australia.; Department of Gynaecological Oncology, Westmead Hospital, Sydney, NSW, Australia., Doherty JA; Department of Population Health Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA., Gentry-Maharaj A; Department of Women's Cancer, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London, UK., Goode EL; Department of Quantitative Health Sciences, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., Goodman MT; Cancer Prevention and Control Program, Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Harris HR; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA., Karlan BY; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., Kaufmann SH; Departments of Medicine and Molecular Pharmacology, Mayo Clinic, Rochester, MN, USA., Kelemen LE; Communicable Disease Epidemiology Section, South Carolina Department of Public Health, Columbia, SC, USA., Köbel M; Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada., Koziak JM; Alberta Health Services-Cancer Care, Calgary, AB, Canada., Le Marchand L; Population Sciences in the Pacifi c Program (Cancer Epidemiology), University of Hawaii Cancer Center, Honolulu, HI, USA., Lester J; David Geffen School of Medicine, Department of Obstetrics and Gynecology, University of California at Los Angeles, Los Angeles, CA, USA., McGuire V; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA., Menon U; UCL Innovative Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Modugno F; Department of Obstetrics, Gynecology and Reproductive Sciences, Division of Gynecologic Oncology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, PA, USA.; Women's Cancer Research Center, Magee-Womens Research Institute and Hillman Cancer Center, Pittsburgh, PA, USA., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA., Pearce CL; Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, USA., Pharoah PDP; Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA, USA., Pike MC; Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.; Department of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Qin B; Cancer Prevention and Control Program, Rutgers Cancer Institute, New Brunswick, NJ, USA., Risch HA; Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA., Rothstein JH; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sarink D; Population Sciences in the Pacifi c Program (Cancer Epidemiology), University of Hawaii Cancer Center, Honolulu, HI, USA., Sieh W; Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Steed H; Department of Obstetrics and Gynecology, University of Alberta, Edmonton, AB, Canada., Terry KL; Obstetrics and Gynecology Epidemiology Center, Department of Obstetrics and, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA., Thompson PJ; Samuel Oschin Comprehensive Cancer Institute, Cancer Prevention and Genetics Program, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Titus LJ; Dartmouth Cancer Center, Lebanon, NH, USA., Van Gorp T; Division of Gynaecologic Oncology, Leuven Cancer Institute, University Hospital Leuven and KU Leuven, Leuven, Belgium., Whittemore AS; Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA., Winham SJ; Department of Quantitative Health Sciences, Division of Computational Biology, Mayo Clinic, Rochester, MN, USA., Jordan SJ; School of Public Health, The University of Queensland, Brisbane, QLD, Australia., Wu AH; Department of Population Health and Public Health Sciences, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Webb PM; Population Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Peres LC; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Merritt MA; The Daffodil Centre, The University of Sydney and Cancer Council NSW, Sydney, NSW, Australia. melissa.merritt@sydney.edu.au.
Corporate Authors: AOCS Group
Source: British journal of cancer [Br J Cancer] 2026 Jun 30. Date of Electronic Publication: 2026 Jun 30.
Publication Type: Journal Article
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-1827
DOI:10.1038/s41416-026-03509-8